phentermine hydrochloride

FDA Drug Profile — Phentermine hydrochloride, Phentermine Hydrochloride

phentermine hydrochloride is listed in the FDA National Drug Code directory with 41 NDC codes, marketed under brand names including Phentermine hydrochloride, Phentermine Hydrochloride. Available dosage forms: capsule, tablet.

Drug details

Generic Name
phentermine hydrochloride
Brand Names
Phentermine hydrochloride, Phentermine Hydrochloride
Application Number
ANDA205017
Sponsor
Bryant Ranch Prepack
NDC Codes
41
Dosage Forms
CAPSULE, TABLET
Routes
ORAL
Active Ingredients
PHENTERMINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Phentermine hydrochloride is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m 2 , or ≥ 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of body mass index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. The limited usefulness of agents of this class, including phentermine, [ see Clinical Pharmacology ( 12.1 , 12.2 ) ] should be measured against possible risk factors inherent in their use such as those described below. Phentermine hydrochloride is a sympathomimetic amine anorectic indicated as a short-term adjunct (a few weeks) in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m 2 , or ≥ 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). The limited usefulness of agents of this class, including Phentermine hydrochloride, should be measured against possible risk factors inherent in their use. 59600473-figure-01

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.